With the refinement provided by the progression likelihood score, it is possible to counsel families more appropriately regarding the actual risk of developing type 1 diabetes and to adjust the child’s follow-up accordingly, including the use of continuous glucose monitoring, which can help assess the child’s insulin requirement [37]. This evidence concerns the gene INS and type 1 diabetes mellitus.